Good MorningEquity markets tried to advance on Monday, hoping a debt-ceiling deal was reached. However, those hopes were dashed by mounting opposition from Republicans and a few Democrats. The news brings the chance of default much closer, which could have far-reaching implications for the market. The caveat is that no-debt-ceiling standoff has yet resulted in a major economic crash or market downturn, and this one is unlikely to do so as well. Interest rates will bring the market down, and there is no indication the FOMC will be cutting rates any time soon.
The next FOMC meeting is in 2 weeks. The odds of another FOMC interest rate hike are 65% due to the hot read on inflation last week. This will put the base rate at 525 basis points and near the top of the cycle. The risk for the market is that inflation will not subside appreciably for several more quarters if then and that rates will remain high indefinitely. In this scenario, investors should expect outflows from equity markets to continue. Featured: The case for trading fewer setups, not more (Ad) 
|
Retail/Wholesale | |
Ulta Beauty Is One Mall Stock You Can Buy
Ulta Beauty (NASDAQ: ULTA) highlights the dichotomy of mall-based retailers; either you have it or you don’t. When it comes to what the public wants, the FQ1 results prove that Ulta definitely has what the consumers want. The company’s result... Read the Full Story |
|
From Our Partners | | Oracle runs 15,000 stocks through the same filter every single day, scanning for precise setups before the opening bell - no emotion, no guesswork.
Tim Bohen, Lead Trainer at StocksToTrade, is walking through this week's flagged setups and showing exactly how the scanner works in a live training right now. | | Watch the scanner in action and join the live training now |
|
Technology | |
Workday Falls Flat On Slowing Growth, Delayed Deals
Workday (NASDAQ: WDAY) is yet another example of a solid yet high-flying company getting its target reeled in. the company did not produce a bad quarter but the Q1 results and outlook suggest the company’s growth and earnings are more tha... Read the Full Story |
|
Technology | |
Broadcom Pops On Results, VMWare Deal
Price action in Broadcom (NASDAQ: AVGO) experienced significant downward pressure over the past two quarters but we think those days are behind the stock. The downward pressure is due in large part to institutional selling that we see ending now the Q2 resul... Read the Full Story |
|
From Our Partners | | Every morning before the market opens, a scanner called Oracle runs through 15,000 stocks and scores the setups — so there's already a plan in place by 6:15 a.m.
Lead Trainer Tim Bohen of StocksToTrade is walking through exactly how Oracle works and how regular traders are using it in a training running right now. | | Watch the Oracle training now and see how the scanner works |
|
Retail/Wholesale | | Building materials supplier Builders FirstSource (NASDAQ: BLDR) stock has been basing for the last month in the bear market as shares are down (-20%) year-to-date. Rising interest rate headwinds are cooling consumer mortgage applications but there’s still a supply shortage of homes that will f... Read the Full Story |
|
Consumer Discretionary | |
It’s been 16 months since GameStop Corp. (NYSE: GME) blasted into the stratosphere fueled by extreme trading euphoria.
Since its abrupt return to Earth, there have been a few minor ignitions but nothing of the epic variety. Still, loyal meme stock enthusiasts have stayed at the ready awaiti... Read the Full Story |
|
From Our Partners | | The U.S. government has taken roughly a 10% stake in Intel, negotiated a 15% cut of Nvidia and AMD chip sales to China, and reportedly received a 5% ownership offer - worth around $40 billion - from the most valuable AI company on earth.
Porter Stansberry calls it the New U.S.A.I. - a state-backed arrangement where Washington and a handful of tech giants are fused at the balance sheet. A small number of companies get pulled inside. Everyone else gets frozen out, including names sitting in your index fund right now. | | Watch the documentary to see which companies are on the right side |
|
Markets | | Retail department store chain Kohl’s Corporation (NYSE: KSS) stock disappointed investors by falling short on both earnings and guidance on its fiscal Q1 2022 earnings report. Shares of the retailer had previously remained at a premium as the Company has stated its intent to explore strategic ... Read the Full Story |
|
Technology | |
Highly-Valued Autodesk Moves Up On Strong Guidance
The price action in Autodesk (NASDAQ: ADSK) has put in a bottom but we don’t think investors should rusk into the stock. While the Q1 results were better than expected and the guidance favorable the margin of outperformance was tepid and t... Read the Full Story |
|
Consumer Discretionary | | Speaker and audio products maker Sonos, Inc. (NASDAQ: SONO) stock has fallen (-26%) for the year selling off with the rest of the bear market. The audio products maker continues to grow both top and bottom lines. Stay-at-home mandates and lockdowns spurred growth in home theater and entertainment au... Read the Full Story |
|
Markets | |
Follow The Upgrades To These Stocks
When we began working on this post the idea was to write up the three most upgraded stocks so far in Q2. Things changed, however, when we discovered that the three most upgraded stocks in Q2 are all energy stocks. In fact, energy stocks hold the top four (4) p... Read the Full Story |
|
Markets | |
On the hunt for dividend stocks with high yields? If you are, one of the easiest ways to choose is to look at a list of solid high-dividend stocks to add to your portfolio. However, if you want to add to your portfolio, it's worth considering a few things, such as the definition of high-yield divi... Read the Full Story |
|
Tuesday's Early Bird Stock Of The Day United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland. | | View Today's Stock Pick |
|
